Bixiye
P69-23 eviCore Healthcare Specialty Utilization Management (UM) Program: Medical Oncology Drug Prior Authorization Updates
Taariikhda uu dhaqangalayo barnaamijka: Okt 02, 2023
Natiijooyinka Raadinta
Soo bandhiga 1271 - 1280 ee natiijooyinka 4229
Bixiye
P70-23 New Medical, Medical Drug and Behavioral Health Policy Management Updates: Effective December 4, 2023
Taariikhda uu dhaqangalayo barnaamijka: Okt 02, 2023
Bixiye
P71-23 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans managed by Blue Cross and Blue Shield of Alabama
Taariikhda uu dhaqangalayo barnaamijka: Okt 02, 2023
Bixiye
P72-23 Claims Reimbursement for Minnesota Health Care Programs
Taariikhda uu dhaqangalayo barnaamijka: Okt 02, 2023
Bixiye
2023 October Bulletins
Taariikhda uu dhaqangalayo barnaamijka: Okt 02, 2023
Bixiye
QP71-23 Register for Webinar | Trauma-Informed Care 102 | Tuesday, September 28, 5-6:30 pm
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 13, 2023
Bixiye
QP72-23 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective November 1, 2023
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 13, 2023
Bixiye
QP73-23 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective October 1, 2023
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 13, 2023
Bixiye
QP74-23 Commercial Pharmacy Benefit Exclusion for Abilify Asimtufii®, Adstiladrin®, Brixadi™, Glydo®, lidocaine 2%, Roctavian™, and Uzedy™
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 13, 2023
Bixiye
QP75-23 MHCP Pharmacy Benefit Exclusion for Adstiladrin®, Brixadi™, and Roctavian™
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 13, 2023